Hsu, Janet <br/><br/>
Enhanced endothelial delivery and biochemical effects of α-galactosidase by ICAM-1-targeted nanocarriers for Fabry disease.  [electronic resource] 

 -  Journal of controlled release : official journal of the Controlled Release Society  Feb 2011 
 - 323-31 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-4995 
<br/><br/><label>Standard No.: </label>10.1016/j.jconrel.2010.10.031  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--chemistry<br/>Antigens, Tumor-Associated, Carbohydrate--metabolism<br/>Cell Line<br/>Drug Carriers--chemistry<br/>Endothelial Cells--immunology<br/>Endothelium, Vascular--cytology<br/>Enzyme Replacement Therapy<br/>Fabry Disease--drug therapy<br/>Humans<br/>Intercellular Adhesion Molecule-1--immunology<br/>Lysosomes--metabolism<br/>Mice<br/>Mice, Inbred C57BL<br/>alpha-Galactosidase--administration & dosage